Human imaging studies demonstrate that glucose utilization by the brain declines with age and is notably impaired in subjects with early AD, which may be related to insulin action in key memory and cognition areas in the brain (Lee et al., 2018). The gene discussed is INS; the disease is Alzheimer disease.